Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The baby must be between 13 and 17 weeks old at the time of joining the trial.
- The baby must have a higher-than-average genetic chance (7–10%) of developing signs of type 1 diabetes by age 6, based on specific gene patterns identified through genetic testing.
- Babies without a close family member with type 1 diabetes may be eligible if they carry certain specific gene combinations and have a genetic risk score above a set level (the exact score depends on whether the baby is male or female — confirm with trial site).
- Babies who have a close family member (such as a parent or sibling) with type 1 diabetes may be eligible based on their gene type, regardless of their genetic risk score (confirm with trial site for specific gene combinations).
- The baby's parent(s) or legal guardian(s) must sign a written consent form agreeing to take part.
Who may not be able to join:
- Babies who have any health condition, illness, or are receiving a treatment that could interfere with the study or put them at risk, as decided by the research doctors.
- Babies who were born prematurely (before 36 weeks of pregnancy).
- Babies who have any condition that might make it difficult to follow the study's requirements consistently.
- Babies who have already been diagnosed with diabetes before joining the trial.
- Babies who are currently taking part in another medical study or using an experimental drug.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Helena Elding Larsson, PhD, Lund University
Phone: +464039113
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Beta-cell health; Beta-cell health
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.